Inflammation and prostate cancer
- PMID: 16526982
Inflammation and prostate cancer
Abstract
There is emerging evidence that prostate inflammation may contribute to prostatic carcinogenesis. Chronic inflammation has been associated with the development of malignancy in several other organs such as esophagus, stomach, colon, liver and urinary bladder. Inflammation is thought to incite carcinogenesis by causing cell and genome damage, promoting cellular turnover, and creating a tissue microenvironment that can enhance cell replication, angiogenesis and tissue repair. Epidemiological data have correlated prostatitis and sexually transmitted diseases with an increased risk of prostate cancer and intake of anti-inflammatory drugs and antioxidants with a decreased risk. Evidence from genetic and molecular studies also support the hypothesis that prostate inflammation and/or infection may be a cause of prostate cancer. In 1999 De Marzo et al proposed that proliferative inflammatory atrophy (PIA) is a precursor to PIN and cancer. Further research will provide opportunities for the discovery and development of strategies for treatment and prevention of prostate cancer.
Similar articles
-
The role of inflammation and infection in the pathogenesis of prostate carcinoma.BJU Int. 2007 Oct;100(4):733-7. doi: 10.1111/j.1464-410X.2007.07091.x. Epub 2007 Jul 23. BJU Int. 2007. PMID: 17662075 Review.
-
Prostate growth and inflammation.J Steroid Biochem Mol Biol. 2008 Feb;108(3-5):254-60. doi: 10.1016/j.jsbmb.2007.09.013. Epub 2007 Sep 7. J Steroid Biochem Mol Biol. 2008. PMID: 17935971 Review.
-
Prostate carcinogenesis and inflammation: emerging insights.Carcinogenesis. 2005 Jul;26(7):1170-81. doi: 10.1093/carcin/bgh317. Epub 2004 Oct 21. Carcinogenesis. 2005. PMID: 15498784 Review.
-
Prostate cancer prevention.Curr Opin Urol. 2007 May;17(3):157-67. doi: 10.1097/MOU.0b013e3280eb110f. Curr Opin Urol. 2007. PMID: 17414513 Review.
-
The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.Eur Urol. 2011 Jul;60(1):106-17. doi: 10.1016/j.eururo.2011.03.055. Epub 2011 Apr 9. Eur Urol. 2011. PMID: 21497433 Review.
Cited by
-
HMGB1: A Promising Therapeutic Target for Prostate Cancer.Prostate Cancer. 2013;2013:157103. doi: 10.1155/2013/157103. Epub 2013 May 12. Prostate Cancer. 2013. PMID: 23766911 Free PMC article.
-
Histological changes caused by meclofenamic acid in androgen-independent prostate cancer tumors: evaluation in a mouse model.Int Braz J Urol. 2015 Sep-Oct;41(5):1002-7. doi: 10.1590/S1677-5538.IBJU.2013.00186. Int Braz J Urol. 2015. PMID: 26689527 Free PMC article.
-
Oxidative stress in prostate hyperplasia and carcinogenesis.J Exp Clin Cancer Res. 2016 Sep 8;35(1):139. doi: 10.1186/s13046-016-0418-8. J Exp Clin Cancer Res. 2016. PMID: 27609145 Free PMC article. Review.
-
Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma.JAMA. 2011 Jul 27;306(4):410-9. doi: 10.1001/jama.2011.1029. JAMA. 2011. PMID: 21791690 Free PMC article.
-
Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?Toxins (Basel). 2019 Sep 19;11(9):547. doi: 10.3390/toxins11090547. Toxins (Basel). 2019. PMID: 31546892 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Medical